Navigation Links


Viread at Biology News

Viread at Biology Products
Viread at Biology Technology
Viread at Medicine News

FDA Approves New HIV Drug, Viread

Biopharmaceutical firm Gilead Sciences Inc. said it has received approval from the US Food and Drug Administration (FDA) to market its antiretroviral agent Viread (tenofovir disoproxil fumarate) for the treatment of HIV in combination with other antiretroviral agents. Like Viread, such drugs work by blocking the process needed for HIV replication in the body. But Viread is the first nu...

Use Of Viread Spreads As New Anti-AIDS Site Is Launched

A website has been unveiled by the Los Angeles County health officials which will facilitate the sending of e-mails to keep people informed of HIV and other related diseases. The site called, inSPOTLA.org is meant // to check the spread of the diseases, and encourage safe sex. The site is targeted at people seeking casual sex on line. A similar site launched in San Francisco in 2004...

Viread To Retail In India For $1

The largest-selling HIV/AIDS drug, Viread is to be made available in India at the special price of $1 (Rs 45) per tablet, according to the manufacturer Gilead.// This announcement was made on Sunday. Gilead has already entered into generic licensing deals with three Indian pharma majors - Emcure Pharmaceuticals, Hetero Drugs and Strides Arcolab - for the drug. The Indian firms will ma...
Viread at Medicine Products
Viread at Medicine Technology

Second Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

FOSTER CITY, Calif.--(BUSINESS WIRE)--June 25, 2007--GileadSciences, Inc. (Nasdaq:GILD) today announced that Study 103, aPhase III clinical trial evaluating the company's once-dailyanti-HIV drug Viread(R) (tenofovir disoproxil fumarate or tenofovirDF) 300 mg as a potential treatment for chronic hepatitis B virus(HBV) infection, met its primary efficacy endpoint. The data showthat Viread...

Second Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun 25, 2007 - GileadSciences, Inc. (Nasdaq:GILD) today announced that Study 103, aPhase III clinical trial evaluating the company's once-dailyanti-HIV drug Viread(R) (tenofovir disoproxil fumarate or tenofovirDF) 300 mg as a potential treatment for chronic hepatitis B virus(HBV) infection, met its primary efficacy endpoint. The data showthat Viread is...

Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun 6, 2007 - GileadSciences, Inc. (Nasdaq:GILD) today announced that Study 102, aPhase III clinical trial evaluating the company's once-dailyanti-HIV drug Viread (tenofovir disoproxil fumarate or tenofovirDF) 300 mg as a potential treatment for chronic hepatitis B virus(HBV) infection, met its primary efficacy endpoint. The study showsthat Viread is no...
Other TagsYanYanYanXIIBioChemiBioChemi
(Date:11/18/2008)...e/ -- The Expand-A-Lung(TM) Breathing Resistance,...imes for breathing fitness,training. Jorge Brouwe...ng,exerciser, manufactures and markets the easy t...i: Send2Press.com/mediaboom/08-1118-ExpndLng_72dpi...ing Resistance Exerciser.), , When asked a...
(Date:11/18/2008)...ire/ -- Just in time for the holiday season,shop...rCancerCures.org to,benefit cancer research at F...w.fhcrc.org ) and 10 other world-class cancer cent...//www.cancerresearchalliance.org ). A portion of,...etworks,( http://www.mallnetworks.com ), the lead...
(Date:11/18/2008)... to Keep you Injury-free this Holiday Season , ...ire/ -- Seasoned travelers have a saying -- " Pac... the fact that most of us bring much more than we ...choing that line, especially, since so many airlin...king luggage. However, if you are one of those pe...
(Date:11/18/2008)...re potent anti-disease effect in postmenopausal wo...althDay News) -- Scientists believe they have foun...e of breast cancer after she,s past menopause, a n... of Texas at Austin found that cutting calories an...t integrates energy balance with cell growth and c...
Breaking Medicine News(10 mins):Health News:Shortness of Breath? Stronger Lungs for Better Breathing (100% Drug Free) 2Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 2Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 3Health News:Lug Your Luggage Safely 2Health News:Lug Your Luggage Safely 3Health News:Diet, Exercise May Modify Breast Cancer Risks 2
(Date:11/17/2008)...ernationally recognized climate scientist and econ...otential role of carbon capture and sequestration ...ssion of the 9th International Conference on Green...n scientists with the Department of Energy,s Pacif...new findings and insights to the greenhouse gas an...
(Date:11/17/2008)...alled, this new small satellite mission sponsored ...igned to help solve the mystery of the most powerf...ere: TGFs, or terrestrial gamma-ray flashes. TGFs ...is the second project under the new NSF CubeSat pr...af of bread, consists of three cubes attached end ...
(Date:11/17/2008)...s of nitrogen deposition associated with industry ...el of acidification, reducing plant growth and pol...blished online in Nature Geoscience . , The stud... the University of Colorado, University of Montana...cal Survey, shows what can happen when nitrogen de...
(Date:11/17/2008)... 1st issue of G&D , Dr. Fred H. Gage (The Salk In...eal a role for the Hippo signaling pathway in the ...ifying new factors and potential therapeutic targ... disorders and neurological tumor formation. , ... print on 11/17 at http://genesdev.org . , Esta...
Breaking Biology News(10 mins):PNNL leadership in carbon sequestration featured at international conference 2Small satellite takes on large thunderstorms 2Acid soils in Slovakia tell somber tale 2New molecular insight into vertebrate brain development 2Mylan Inc NATCO Pharma Ltd To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone 28R 29 21421 1Mylan Inc NATCO Pharma Ltd To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone 28R 29 21421 2China Sky One Medical Inc Announces Guidance for Second Quarter and Full Year 2008 21416 1China Sky One Medical Inc Announces Guidance for Second Quarter and Full Year 2008 21416 2China Sky One Medical Inc Announces Guidance for Second Quarter and Full Year 2008 21416 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel a Leading Oral Taxane 5897 1Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel a Leading Oral Taxane 5897 2Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel a Leading Oral Taxane 5897 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel a Leading Oral Taxane 5897 4NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 21409 1NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 21409 2
Other Contentsaneurysmaneurysmaneurysmbranchialyouryouryouryouryouryouryouryouryourodorodorodorodorbreastfeedingbreastfeedingbreastfeedingbreastsbreasts